Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		147,309,254	423,170,610
Beginning balance at Dec. 31, 2021	$ 2,186,700	$ 15	$ 42	$ 4,645,800	$ (1,244)	$ (2,457,913)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	270,089			270,089
Issuance of common stock upon settlement of restricted stock units (RSUs) (in shares)		10,658,728
Issuance of common stock upon settlement of restricted stock units (RSUs)	0	$ 1		(1)
Issuance of common stock upon exercise of stock options (in shares)		123,171
Issuance of common stock upon exercise of stock options	614			614
Issuance of common stock for employee stock purchase plan (in shares)		770,966
Issuance of common stock for employee stock purchase plan	20,380			20,380
Common stock withheld related to net share settlement of equity awards	(208,920)			(208,920)
Net loss	(292,325)					(292,325)
Foreign currency translation adjustment	(448)				(448)
Ending balance (in shares) at Mar. 31, 2022		158,862,119	423,170,610
Ending balance at Mar. 31, 2022	1,976,090	$ 16	$ 42	4,727,962	(1,692)	(2,750,238)
Beginning balance (in shares) at Dec. 31, 2022		170,687,065	423,170,610
Beginning balance at Dec. 31, 2022	1,904,020	$ 17	$ 42	5,428,297	(4,945)	(3,519,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	236,027			236,027
Issuance of common stock upon settlement of restricted stock units (RSUs) (in shares)		10,596,029
Issuance of common stock upon settlement of restricted stock units (RSUs)	$ 0	$ 1		(1)
Issuance of common stock upon exercise of stock options (in shares)	116,000	116,278
Issuance of common stock upon exercise of stock options	$ 866			866
Issuance of common stock for employee stock purchase plan (in shares)		1,728,138
Issuance of common stock for employee stock purchase plan	19,965			19,965
Common stock withheld related to net share settlement of equity awards	(2,849)			(2,849)
Net loss	(258,964)
Foreign currency translation adjustment	751				751
Ending balance (in shares) at Mar. 31, 2023		183,127,510	423,170,610
Ending balance at Mar. 31, 2023	$ 1,899,816	$ 18	$ 42	$ 5,682,305	$ (4,194)	$ (3,778,355)